EMA human medicine committee recommends approval of Sanofi’s Sarclisa to treat transplant-ineligible newly diagnosed multiple myeloma: Paris Saturday, November 16, 2024, 09:00 H ...

Health stocks slumped on Friday as Wall Street weighed the impact that prominent vaccine skeptic Robert F. Kennedy Jr. could ...

In a report released on November 14, David Evans from Kepler Capital maintained a Buy rating on Merck KGaA (0O14 – Research Report), ...

Many scientists at the federal health agencies await the second Donald Trump administration with dread as well as uncertainty ...

Vaccine makers hit hardest as Robert F. Kennedy Jr. appointment to Department of Health raises concerns for US drug market.

French drug company Sanofi, whose website boasts its products vaccinate over 500 million annually, tumbled nearly 3.5%.

Europe's STOXX 600 fell on Friday, dragged by technology and healthcare stocks, keeping the index on track for its fourth ...

The intersection at Mitchell Avenue and the Belt Highway will see construction starting on Monday, Nov. 18. Missouri American ...

AstraZeneca and GSK fell as the president-elect named Kennedy as his pick for the role overseeing the US's rules on medicine, ...

The now defunct airline issued over 93,000 “First Moon Flights” Club cards to those who wanted a seat on the first commercial ...

The MHRA has approved Novavax’s updated Nuvaxovid vaccine for the latest subvariant in individuals aged 12 and older. This ...

Zai Lab has priced its public offering at $25.50 per share, targeting $200 million for corporate purposes. The fundraising ...